Glatt Pharmaceutical Services and Aprecia to Advance Patient Focused Pharmaceuticals with Aprecia’s 3D-Printing Technology
Aprecia’s compression-free 3DP manufacturing platform expands Glatt capabilities in innovative particle design
BINZEN, Germany and CINCINNATI, Ohio —Glatt Pharmaceutical Services and Aprecia announce their joint effort to accelerate and expand the use of Glatt’s multiparticulate technologies through Aprecia’s 3DP manufacturing. This unprecedented team effort will focus on overcoming oral pharmaceutical design challenges presented by conventional manufacturing.